News

Importantly, the study also demonstrated improvement in patient functioning, as measured by the personal and social performance scale (PSP) across a wide range of doses. This is the

The collaboration is intended to capitalize on Xoma's comprehensive antibody discovery, development and production technologies and expertise. Under the agreement, Schering-Plough will make up-front and milestone payments to

The specialty pharmaceutical firm has successfully completed a pharmacokinetics and scintigraphy study with fluticasone propionate, a commonly prescribed inhaled steroid treatment for asthma, in combination with Ventaira's next-generation

New data from several ongoing respiratory disease programs including pandemic flu, asthma, chronic obstructive pulmonary disorder (COPD), and idiopathic pulmonary fibrosis (IPF) were presented at the American Thoracic

Named PROTECT, the Peg-intron (peginterferon alfa-2b) plus Rebetol (ribavirin, USP) trial is targeted to enroll 125 hepatitis C virus (HCV) patients at approximately 28 liver transplant centers across

ZK-EPO is a novel epothilone that was strategically designed to overcome the limitations associated with other microtubule stabilizing agents by combining high potency with a wide therapeutic window.

The research, which has been published in Clinical Cancer Research, was authored by Dr Brittney-Shea Herbert and colleagues at Indiana University Cancer Center, along with Geron scientists. The

The primary objective of the alliance is to identify active molecules and bring them forward to clinical proof of concept, yielding novel candidates for drug development in various

Alamo's sales force is currently marketing FazaClo (clozapine, USP), the only orally-disintegrating formulation of clozapine for the management of severely ill schizophrenic patients who fail to respond adequately